JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Fluorescence-activated cell sorting: A comprehensive guide

Understanding the principles, applications, and advancements in FACS for research and clinical applications.

Search our range of primary antibodies validated for flow cytometry

View Products
button-secondary

Fluorescence-activated cell sorting (FACS) is one of the most effective, widely used, laser-based methods for isolating and analyzing individual cells from a heterogeneous mixture based on their physical and fluorescent characteristics.

FACS utilizes flow cytometry to measure fluorescence intensity emitted by fluorescently labeled antibodies that bind to specific cell-associated molecules, such as propidium iodide (PI) binding to DNA1.

Fluorescence-activated cell sorting has numerous applications, particularly in drug development, enabling researchers to isolate rare cell populations and identify biomarkers present on these cells2. This process aids in uncovering potential drug targets3. Additionally, FACS is valuable in diagnostics, helping to identify abnormal cell populations such as tumors or altered immune cell types4. This capability offers key insights into diseases and supports the development of personalized medicine by enabling early classification and targeted therapeutic strategies.

Thus, FACS enables high-throughput analysis and sorting while also discriminating between cells, leading to a better understanding of disease and the development of more targeted therapeutics.

Principles of FACS

Fluorescence is used to identify and characterize individual cells. Fluorophores, which are fluorescent molecules, are attached to specific antibodies or dyes that bind to cell surface markers or intracellular components. Upon illumination with a particular wavelength of light, these fluorophores emit light, thus allowing the cells to be distinguished from each other based on their fluorescence intensity.

Key components of a FACS system

The FACS system comprises several important components that work together to accurately and efficiently sort cells5.

Sorting mechanism

The sorting mechanism employs an electrical charging ring to apply a charge to droplets containing cells based on their fluorescence characteristics. This allows the droplets to be deflected by an electrostatic system into different collection tubes according to their charge6.

FACS vs. flow cytometry

Flow cytometry and FACS are powerful techniques used in cell biology to analyze cells based on their physical and fluorescent characteristics. Flow cytometry is primarily an analytical technique that measures the physical and chemical properties of cells as they flow in a fluid stream. This method allows for the simultaneous analysis of multiple parameters, including cell size, granularity, and the expression of specific surface markers7. By utilizing fluorescently labeled antibodies, it generates comprehensive data on cell size, complexity, and fluorescence intensity.

Comparison between FACS and flow cytometry aspects

FACS and analytical flow cytometry are closely related procedures; however, FACS extends analytical flow cytometry by enabling the physical sorting of bulk or even single cells based on their analyzed properties, thus providing highly specific information about individual cells.

Aspects
FACS
Flow cytometry
Definition
Specialized flow cytometry that sorts cells
Analytical technique for measuring cell properties
Sorting capability
Ability to sort cells based on fluorescence
Limited or absent
Instrumentation
Requires additional sorting components
Simpler setup with one or more lasers
Complexity
More complex due to sorting mechanisms
Relatively simple

Understanding when to apply FACS vs. flow cytometry in research

Although flow cytometry and FACS are often used interchangeably, they serve different purposes within the realm of cellular analysis8. Flow cytometry is optimally suited for high-throughput analysis and general characterization of cell populations, while FACS excels in isolating specific cells for detailed study. Understanding these differences is essential for researchers to choose the appropriate method based on their experimental requirements.

FACS workflow: From sample preparation to sorting

FACS is a complex procedure that starts with sample preparation and ends with the analysis of results. Sample preparation is vital to ensuring accurate and reliable cell analysis.

Sample preparation for FACS

Sample preparation for FACS involves several key steps.

Sorting process

Once the cells are tagged and processed, they are passed through a flow cytometer. The equipment utilizes lasers to excite the fluorescent dyes, and detectors measure the intensity of the fluorescence generated by each cell.

The sorting process typically includes two parameters: forward scatter (FSC) and side scatter (SSC)10.

Data acquisition and analysis

FACS reagents and antibodies

Role of antibodies in FACS

Antibodies are integral to FACS, enabling the precise identification and isolation of specific cell populations based on unique markers. These antibodies are conjugated to fluorophores, which emit fluorescence upon laser excitation, facilitating the detection and sorting process.

High-quality antibodies are indispensable for achieving reliable and reproducible results in FACS experiments.

Reagents for optimal sorting

Reagents play a vital role in ensuring the efficiency and accuracy of FACS processes. They support cell viability, minimize artifacts, and optimize labeling for sorting.

Optimized and experiment-specific reagents enable researchers to control and enhance FACS accuracy and reliability while maintaining cell viability and minimizing artifacts.

Applications of FACS

FACS has a wide range of applications in both science and therapeutic development.

Research applications

FACS is extensively applied in research, especially in cancer research, immunology, and stem cell research.

Clinical applications

FACS is considered important in various therapeutic applications, especially in cell-based therapeutics and diagnostics.

Emerging and future applications

While rapid advancements are being made in personalized medicine and biotechnology, new applications for FACS continue to emerge.

Integration with single-cell sequencing technologies and personalized medicine

FACS plays a pivotal role in single-cell genomics by enabling the precise isolation of individual cells based on specific surface markers. This is vital for downstream applications like single-cell RNA sequencing (scRNA-seq), which provides detailed transcriptomic profiles of individual cells34.

This integration is vital for personalized medicine, as it allows researchers to identify and isolate specific cell populations associated with diseases, such as cancer or autoimmune disorders. By analyzing the unique molecular signatures of these cells, researchers can develop targeted therapies tailored to individual patients.

FACS is also used to ensure quality control of cells used in cell-based therapies, a large part of personalized medicine. Its ability to generate highly purified cell preparations from large starting materials, vital for therapies like adoptive T-cell therapy, where specific immune cells (eg, Treg) are isolated and expanded for patient treatment, is a key advantage35.

FACS in biotechnology and environmental research

FACS is increasingly applied in biotechnology, particularly in protein production and microbial population analysis36, 37. Its ability to rapidly analyze and sort microorganisms in environmental samples has revolutionized the study of complex microbial communities.

For example, FACS has transformed the study of marine photosynthetic planktonic and bacterial populations, revealing complex behaviors and interactions that were previously inaccessible38. This has led to the discovery of new taxa and contributed to a deeper understanding of the ecological roles of these microorganisms in global processes like the carbon cycle.

FACS provides the ability to explore the physiological diversity of microbial populations at a single-cell level, overcoming the limitations of traditional cultivation methods and revealing previously hidden diversity within seemingly uniform populations39.

Advanced FACS technologies

FACS continues to evolve, with advancements in both techniques and equipment, driving more accurate and complex applications in research and clinical settings.

Multicolor FACS

Multicolor FACS enables simultaneous detection of numerous cell markers using various fluorophores, allowing detailed examination of complex cell populations and revealing previously obscured relationships, enhancing the depth of data analysis12. When designing a multicolor flow cytometry panel, it is recommended to pair the brightest fluorophores, such as PE or APC, with low-abundance targets and weaker fluorophores to detect targets present in a higher abundance.

Single-cell sorting

Single-cell sorting isolates individual cells for functionally defined cell therapies and high-resolution studies in genomes, proteomics, and drug development40. Analyzing single cells provides insights into disease mechanisms and personalized medicines by revealing distinct cellular activities, gene expression patterns, and treatment responses.

New developments in FACS technology are pushing the boundaries of cell sorting and analysis

Advantages and limitations of FACS

FACS offers high specificity and purity, along with the ability to select viable cell populations based on multiple parameters simultaneously. However, it is limited by the requirement for specialized equipment, highly skilled operators, and significant expense compared to other techniques.

Advantages of using FACS

FACS provides several significant benefits that make it an indispensable tool in research and therapeutic settings.

Limitations and challenges

Optimizing FACS protocols

FACS protocols can be optimized to enhance sorting efficiency and reduce errors44. The following tips and strategies are recommended.

Tips for improving sorting efficiency

Troubleshooting FACS issues

FACS compared to other cell sorting methods

Aside from FACS, other cell sorting techniques include MACS and microfluidic. Here are some of the noted comparisons between them.

FACS vs. MACS

Magnetic-activated cell sorting (MACS) isolates specific cell types using magnetic beads conjugated to antibodies that bind to target cell markers, separating cells through a magnetic field.

Unlike FACS, MACS is generally more straightforward, less expensive, and capable of processing larger volumes. According to a study, MACS sorts resulted in only 7–9% cell loss compared to ~70% for FACS, 4–6 times faster processing than FACS, and improved throughput due to parallel processing45. However, FACS delivers superior resolution, multiparameter analysis, and live cell sorting.

FACS vs. microfluidic sorting

Microfluidic sorting uses lab-on-a-chip devices to separate cells based on their physical properties, offering advantages in precision, lower sample volume, and faster processing times compared to traditional FACS.

Microfluidic sorting devices are compact and can automate processes on a smaller scale, contrasting with FACS's complex fluid dynamics. Microfluidic devices can improve safety, eliminate potentially biohazardous aerosols, and simplify protocols46. While FACS excels in high-throughput applications and multiparameter analysis, microfluidic sorting is promising for more precise, low-volume, and affordable high-resolution cell separation activities.

Future of FACS

FACS is rapidly advancing, with emerging trends and technologies poised to expand its capabilities. The future of FACS promises transformative progress across multidisciplinary areas, driven by technological advancements and applications in cell biology research, diagnostics, and therapeutics.

Enhanced resolution and speed: With the advent of spectral flow cytometry, which uses multiple fluorescence channels, FACS systems will be able to analyze an even larger number of parameters simultaneously, enabling researchers to gain a deeper understanding of cell populations. This enhanced capability will facilitate more complex and precise profiling of individual cells, improving our understanding of cellular heterogeneity, disease mechanisms, and treatment responses.

AI-driven data analysis and machine learning: AI can identify subtle patterns in large datasets, yielding more accurate and reliable outcomes. This integration will improve the accuracy of cell sorting, automate analysis of complex data, and help predict patient outcomes in clinical settings. Additionally, machine learning models can optimize the selection and enhancement of specific cell types essential for therapies, enabling highly personalized treatments.

Single-cell omics integration: It is also transforming FACS by offering detailed insights into gene expression, protein profiles, and other biological properties at the single-cell level47. This enhances sorting precision and improves understanding of cellular heterogeneity in disease. Spectral flow cytometry will further increase the capability of FACS by assessing numerous markers at the same time with a broader range of fluorophores, improving the resolution of complex cell populations. This will facilitate a better understanding of cellular functions and the identification of therapeutic drug targets.

Additionally, FACS-based technologies will enable rapid biomarker identification for various diseases, improving diagnostic precision and facilitating early detection of cancers and autoimmune disorders.

In personalized medicine, FACS is crucial for isolating cell populations for targeted therapy48. Its ability to extract cells based on unique identifiers enables patient-specific profiling, leading to tailored approaches such as immunotherapy and stem cell therapy. This will allow for more effective therapies with fewer side effects, resulting in patient-centered care.

FACS’s future in regenerative medicine also looks promising49. Its ability to isolate specific cell types with precision will enable personalized stem cell therapies, advancing tissue regenerationandorgan repair techniques.

FAQs

What is FACS, and how does it work?

FACS (fluorescence-activated cell sorting) is a powerful technology used to separate and analyze individual cells based on their fluorescent characteristics. This procedure involves labeling cells with fluorescently conjugated antibodies that bind to specific cell markers. As the labeled cells pass through a laser beam, the emitted fluorescence is detected and analyzed. The cells are then sorted into different populations based on their fluorescence profile. For example, FACS can sort cancerous cells from normal cells by detecting specific biomarkers expressed on the surface of the cancer cells.

What types of cells can be analyzed using FACS?

FACS can analyze a broad array of cells, including immune cells, stem cells, and cancer cells. For instance, FACS analyzes different types of white blood cells, such as T-cells, B-cells, and dendritic cells, based on surface markers like CD3, CD19, and CD11c. In cancer research, FACS can identify and isolate tumor cells by detecting markers like HER2 (a breast cancer marker) or CD44 (a marker of cancer stem cells).

What are the key markers for identifying myeloid cells in FACS?

Myeloid cells, which encompass monocytes, dendritic cells, tissue macrophages and granulocytes, have gained increased recognition as a crucial component of the tumor microenvironment. Consequently, they have emerged as promising targets for anti-cancer therapies. Key markers used in FACS for identifying myeloid cells include CD11b, CD33, CD14, CD15, CD16, and HLA-DR50.

How do activation and differentiation markers differ in flow cytometry?

Activation markers are expressed on the cell surface when cells are stimulated by stimuli such as cytokines or viruses in flow cytometry. Examples are CD69, CD25, and CD40. Differentiation markers, conversely, indicate the stage of cell development or lineage commitment, such as CD4, CD8, or CD14 for certain immune cell types.

How do you differentiate between T cell and B cell markers in FACS?

Differentiating between T cell and B cell markers in FACS is crucial for immunophenotyping and understanding immune responses. This process involves the simultaneous detection of various markers using multiple fluorescently labeled antibodies. This approach enhances the ability to differentiate between T and B cells effectively, especially when analyzing complex samples with overlapping populations.

What are the functional markers used in FACS?

Functional markers in FACS are important for assessing various cellular properties beyond simple identification. These markers provide insights into the functional status of cells, including their activation, proliferation, and differentiation states. Examples include:

Search our range of secondary antibodies validated for flow cytometry

View Products
button-secondary

Flow cytometry protocol

Learn more
button-secondary

Fluorescence-activated cell sorting (FACS) of live cells

Learn more
button-secondary

Flow cytometry training

Learn more
button-secondary

References

1.     Crowley, L. C., Scott, A. P., Marfell, B. J., et al. Measuring cell death by propidium iodide uptake and flow cytometry. Cold Spring Harbor Protocols. 2016, pdb-prot087163 (2016).

2.     Sabines-Chesterking, J., Burenkov, I. A., & Polyakov, S. V. Quantum measurement enables single biomarker sensitivity in flow cytometry. Scientific Reports14, 3891 (2024).

3.     Heath, J. R., Ribas, A., & Mischel, P. S. Single-cell analysis tools for drug discovery and development. Nature reviews Drug discovery. 15, 204–216 (2016).

4.     Gostomczyk, K., Łukaszewska, E., Borowczak, J., et al. Flow cytometry in the detection of circulating tumor cells in neoplastic effusions. Clinica Chimica Acta. 552, 117651 (2024).

5.     Cho, S. H., Chen, C. H., Tsai, F. S., et al. Human mammalian cell sorting using a highly integrated micro-fabricated fluorescence-activated cell sorter (μFACS). Lab on a Chip. 10, 1567–1573 (2010).

6.     Vitelli, M., Budman, H., Pritzker, M., et al. Applications of flow cytometry sorting in the pharmaceutical industry: A review. Biotechnology Progress. 37, e3146 (2021).

7.     Lakschevitz, F. S., Hassanpour, S., Rubin, A., et al. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Experimental cell research342, 200–209 (2016).

8.     Bleichrodt, R. J., & Read, N. D. Flow cytometry and FACS applied to filamentous fungi. Fungal Biology Reviews33, 1–15 (2019).

9.     dos Santos Fagundes, I., Brendler, E. P., Nunes Erthal, I. et al. Total Th1/Th2 cytokines profile from peripheral blood lymphocytes in normal pregnancy and preeclampsia syndrome. Hypertension in Pregnancy41, 15–22 (2022).

10.  Ortolani, C. Signals: Scattering. In  Flow Cytometry Today: Everything You Need to Know about Flow Cytometry.  11–21 (2022).

11.  den Braanker, H., Bongenaar, M., & Lubberts, E. How to prepare spectral flow cytometry datasets for high dimensional data analysis: A practical workflow. Frontiers in immunology12, 768113 (2021).

12.  Holmberg-Thyden, S., Grønbæk, K., Gang, A. O., et al. A user's guide to multicolor flow cytometry panels for comprehensive immune profiling. Analytical biochemistry627, 114210 (2021).

13.  Renner, P., Crone, M., Kornas, M., et al. Intracellular flow cytometry staining of antibody-secreting cells using phycoerythrin-conjugated antibodies: pitfalls and solutions. Antibody Therapeutics5, 151–163 (2022).

14.  Pandhari, R. M. R., & Taranath, T. C. In-vitro Antioxidant Activity and Flow Cytometric Analysis of Simarouba glauca DC Bark Extract Induced Apoptosis in Triple Negative Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention: APJCP25, 201 (2024).

15.  Seong, Y., Nguyen, D. X., Wu, Y., et al. Novel PE and APC tandems: Additional near‐infrared fluorochromes for use in spectral flow cytometry. Cytometry Part A101, 835–845 (2022).

16.  Sakib, M. S., Sokpor, G., Nguyen, H. P., et al. Intranuclear immunostaining-based FACS protocol from embryonic cortical tissue. Star Protocols2, 100318 (2021).

17.  Phan, H. V., van Gent, M., Drayman, N., et al. High-throughput RNA sequencing of paraformaldehyde-fixed single cells. Nature Communications12, 5636 (2021).

18.  Mostböck, S., Wu, H. H., Fenn, T., et al. Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction. Frontiers in Immunology13, 862757 (2022).

19.  Sugimoto, C., Fujita, H., & Wakao, H. A flow-cytometry-based assay to assess the cytolytic activity against tumor cells by combination of mouse MAIT cells and natural killer cells. STAR protocols4, 102620 (2023).

20.  Artemenko, E. O., Obydennyi, S. I., & Panteleev, M. A. Approach for Analysis of Intracellular Markers in Phosphatidylserine-Positive Platelets. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology18, 296–302 (2024).

21.  DaMata, J. P., Zelkoski, A. E., Nhan, P. B., et al. Dissociation protocols influence the phenotypes of lymphocyte and myeloid cell populations isolated from the neonatal lymph node. Frontiers in Immunology15, 1368118 (2024).

22.  Chaurasia, R. K., Shirsath, K. B., & Sapra, B. K. Protocol for one-step selective lysis of red blood cells and platelets with long-term preservation of white blood cells (human) at ambient temperature. STAR protocols2, 100834 (2021).

23.  Ingelshed, K., Melssen, M. M., & Spiegelberg, D. Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry. STAR protocols6, 103505 (2025).

24.  Heuston, E. F., Doumatey, A. P., Naz, F., et al. Optimized methods for scRNA-seq and snRNA-seq of skeletal muscle stored in nucleic acid stabilizing preservative. Communications Biology8, 10 (2025).

25.  Junker, F., & Camillo Teixeira, P. Barcoding of live peripheral blood mononuclear cells to assess immune cell phenotypes using full spectrum flow cytometry. Cytometry Part A101, 909–921 (2022).

26.  Mayol, J. F., Loeuillet, C., Hérodin, F., et al. Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells. Bioessays31, 993-1001 (2009).

27.  Fei, C., Nie, L., Zhang, J., et al. Potential applications of fluorescence-activated cell sorting (facs) and droplet-based microfluidics in promoting the discovery of specific antibodies for characterizations of fish immune cells. Frontiers in Immunology12, 771231 (2021).

28.  Zhu, B., & Murthy, S. K. Stem cell separation technologies. Current opinion in chemical engineering2, 3–7 (2013).

29.  Sharon, Y., Alon, L., Glanz, S., et al. Isolation of normal and cancer-associated fibroblasts from fresh tissues by Fluorescence Activated Cell Sorting (FACS). Journal of visualized experiments: JoVE. 71, 4425 (2013).

30.  Soh, K. T., Tario Jr, J. D., & Wallace, P. K. Diagnosis of plasma cell dyscrasias and monitoring of minimal residual disease by multiparametric flow cytometry. Clinics in laboratory medicine37, 821 (2017).

31.  Jelínek, T., Bezdekova, R., Zatopkova, M., et al. Current applications of multiparameter flow cytometry in plasma cell disorders. Blood cancer journal7, e617–e617 (2017).

32.  Moon, J. H., Kim, G., Park, S. B., et al. The importance of FACS analysis in the development of aptamers specific to pathogens. Journal of Biosystems Engineering39, 111–114 (2014).

33.  Galbraith, D. W., Anderson, M. T., & Herzenberg, L. A. Flow cytometric analysis and FACS sorting of cells based on GFP accumulation. Methods in cell biology58, 315–341 (1998).

34.  Jovic, D., Liang, X., Zeng, H., et al. Single‐cell RNA sequencing technologies and applications: A brief overview. Clinical and translational medicine12, e694 (2022).

35.  Amini, L., Kaeda, J., Fritsche, E., et al. Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective. Frontiers In Cell and Developmental Biology10, 1081644 (2023).

36.  Grünberger, A., Probst, C., Helfrich, S., et al. Spatiotemporal microbial single‐cell analysis using a high‐throughput microfluidics cultivation platform. Cytometry Part A87, 1101–1115 (2015).

37.  Pereira, A. C., Tenreiro, A., & Cunha, M. V. When FLOW-FISH met FACS: Combining multiparametric, dynamic approaches for microbial single-cell research in the total environment. Science of The Total Environment806, 150682 (2022).

38.  Petersen, T. W., Harrison, C. B., Horner, D. N., et al. Flow cytometric characterization of marine microbes. Methods57, 350–358 (2012).

39.  Müller, S., & Nebe-von-Caron, G. Functional single-cell analyses: flow cytometry and cell sorting of microbial populations and communities. FEMS Microbiology reviews34, 554–587 (2010).

40.  Miwa, H., Dimatteo, R., de Rutte, J., et al. Single-cell sorting based on secreted products for functionally defined cell therapies. Microsystems & Nanoengineering8, 84 (2022).

41.  McCausland, M., Lin, Y. D., Nevers, T., et al. With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials. Bioanalysis13, 1597–1616 (2021).

42.  Tracey, L. J., An, Y., & Justice, M. J. CyTOF: An emerging technology for single‐cell proteomics in the mouse. Current Protocols1, e118 (2021).

43.  Gualdrón-López, M., Díaz-Varela, M., Toda, H., et al. Multiparameter flow cytometry analysis of the human spleen applied to studies of plasma-derived EVs from Plasmodium vivax patients. Frontiers in Cellular and Infection Microbiology11, 596104 (2021).

44.  Hawley, T. S., & Hawley, R. G. (Eds.).  Flow cytometry protocols  (Vol. 2779). Springer Nature (2024).

45.  Sutermaster, B. A., & Darling, E. M. Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting. Scientific reports9, 227 (2019).

46.  Shields Iv, C. W., Reyes, C. D., & López, G. P. Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation. Lab on a Chip15, 1230–1249 (2015).

47.  Leonavicius, K., Nainys, J., Kuciauskas, D., et al. Multi-omics at single-cell resolution: comparison of experimental and data fusion approaches. Current Opinion in Biotechnology55, 159–166 (2019).

48.  Liu, Y., Rao, P., Qian, H., et al. Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis. Advanced Science10, 2204998 (2023).

49.  Esteves, C. L., & Donadeu, F. X. Pericytes and their potential in regenerative medicine across species. Cytometry Part A93, 50–59 (2018).

50.  Aanei, C. M., Veyrat-Masson, R., Rigollet, L., et al. Advanced flow cytometry analysis algorithms for optimizing the detection of “different from normal” immunophenotypes in acute myeloid blasts. Frontiers in Cell and Developmental Biology9, 735518 (2021).